| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.088 | 0.03 |